| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Gossamer Bio, Inc. | EVP, Tech Ops and Admin | Common Stock | 711K | $1.89M | $2.66 | Oct 1, 2025 | Direct |
| HERON THERAPEUTICS, INC. /DE/ | Director | Common Stock | 84.1K | $222K | $2.64 | Jan 31, 2025 | Direct |
| Gossamer Bio, Inc. | EVP, Tech Ops and Admin | Common Stock | 45.9K | $122K | $2.66 | Oct 1, 2025 | By family trust |
| HERON THERAPEUTICS, INC. /DE/ | Director | Stock Option (Right to Buy) | 35.9K | $62.1K | $1.73 | Jan 31, 2025 | Direct |
| Gossamer Bio, Inc. | EVP, Tech Ops and Admin | Common Stock | 22.2K | $59.1K | $2.66 | Oct 1, 2025 | By trust FBO son |
| Gossamer Bio, Inc. | EVP, Tech Ops and Admin | Stock Option (Right to Buy) | 440K | Mar 4, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| GOSS | Gossamer Bio, Inc. | Oct 1, 2025 | 1 | $0 | 4 | Oct 2, 2025 | EVP, Tech Ops and Admin |
| GOSS | Gossamer Bio, Inc. | Mar 4, 2025 | 1 | $0 | 4 | Mar 6, 2025 | EVP, Tech Ops and Admin |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | Jan 31, 2025 | 2 | $0 | 4/A | Feb 4, 2025 | Director |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | Jan 30, 2025 | 2 | $62.1K | 4 | Feb 3, 2025 | Director |
| GOSS | Gossamer Bio, Inc. | Mar 27, 2024 | 1 | -$7.43K | 4 | Mar 28, 2024 | EVP, Tech Ops and Admin |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | Jan 19, 2024 | 2 | $0 | 4 | Jan 19, 2024 | Director |
| GOSS | Gossamer Bio, Inc. | Jan 2, 2024 | 1 | $0 | 4 | Jan 4, 2024 | EVP, Tech Ops and Admin |
| GOSS | Gossamer Bio, Inc. | Nov 20, 2023 | 1 | $0 | 4 | Nov 22, 2023 | EVP, Tech Ops and Admin |
| GOSS | Gossamer Bio, Inc. | Jul 24, 2023 | 2 | $25K | 4 | Jul 26, 2023 | EVP, Tech Ops and Admin |
| GOSS | Gossamer Bio, Inc. | May 5, 2023 | 8 | $0 | 4 | May 9, 2023 | EVP, Tech Ops and Admin |
| GOSS | Gossamer Bio, Inc. | Mar 20, 2023 | 2 | $22.1K | 4 | Mar 22, 2023 | EVP, Tech Ops and Admin |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | Dec 16, 2022 | 2 | $0 | 4 | Dec 20, 2022 | Director |
| GOSS | Gossamer Bio, Inc. | Dec 7, 2022 | 1 | $0 | 4 | Dec 9, 2022 | EVP, Tech Ops and Admin |
| GOSS | Gossamer Bio, Inc. | Jul 15, 2022 | 1 | $50K | 4 | Jul 15, 2022 | EVP, Tech Ops and Admin |
| GOSS | Gossamer Bio, Inc. | Mar 23, 2022 | 1 | -$95.6K | 4 | Mar 24, 2022 | EVP, Tech Ops and Admin |
| GOSS | Gossamer Bio, Inc. | Jan 6, 2022 | 1 | $0 | 4 | Jan 10, 2022 | EVP & General Counsel |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | Dec 21, 2021 | 3 | -$2.92K | 4 | Dec 23, 2021 | Director |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | Sep 21, 2021 | 1 | -$3.69K | 4 | Sep 23, 2021 | Director |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | Jun 21, 2021 | 1 | -$4.56K | 4 | Jun 22, 2021 | Director |